Fast M&A, Furious Supply Chains: Pharma’s Race for Resilience

6 min read

watercolor painting that represents the pharmaceutical industry, focusing on mergers and acquisitions within the life sciences sector

Explore Big Pharma’s M&A trends, their impact on supply chains, and the urgent need for adaptability in a rapidly evolving healthcare landscape However, researching partnerships, acquisitions, and divestments made by large multinational firms over time reveals trends and evolutionary patterns in the ecosystem. In this article, I will consider some mergers and acquisitions transactions to extrapolate how life sciences will change shortly. I will start by exploring the information available in the last decade’s financial statements of large life science firms to gain a quantitative idea of how serious they have been around the change. I will end by exploring the potential implications of these…...

This article is free to read

Login to read the full article


By subscribing to our main site, you will also be subscribed to DDIntel - our regular letter showcasing our featured articles and applications.

Flavio Aliberti Flavio Aliberti brings with him a 23-year track record in consulting around business intelligence, change management, strategy, M&A transformation, IT and SOX auditing for high regulated domains, like Insurance, Airlines, Trade Associations, Automotive, and Pharma. He holds an MSc in Space Aeronautic Engineering from the University of Naples and an MSc in Advanced Information Technology and Business Management from the University of Wales.